Daito Pharmaceutical Co.,Ltd. (4577.T)
JPY 2025.0
(0.75%)
JPY 2025.0
(0.75%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.89 Billion JPY | 14.54% |
| 2022 | 18.23 Billion JPY | 8.43% |
| 2021 | 16.82 Billion JPY | 6.78% |
| 2020 | 15.75 Billion JPY | 29.85% |
| 2019 | 12.13 Billion JPY | 20.59% |
| 2018 | 10.05 Billion JPY | 8.06% |
| 2017 | 9.3 Billion JPY | 9.6% |
| 2016 | 8.49 Billion JPY | 21.61% |
| 2015 | 6.98 Billion JPY | 30.49% |
| 2014 | 5.35 Billion JPY | 20.64% |
| 2013 | 4.43 Billion JPY | 10.42% |
| 2012 | 4.01 Billion JPY | 17.53% |
| 2011 | 3.41 Billion JPY | -1.92% |
| 2010 | 3.48 Billion JPY | 19.79% |
| 2009 | 2.9 Billion JPY | -6.09% |
| 2008 | 3.09 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 21.59 Billion JPY | 3.37% |
| 2023 Q2 | 19.94 Billion JPY | 4.89% |
| 2023 FY | 20.89 Billion JPY | 14.54% |
| 2023 Q3 | 21.31 Billion JPY | 6.85% |
| 2023 Q4 | 20.89 Billion JPY | -1.99% |
| 2023 Q1 | 19.01 Billion JPY | 4.28% |
| 2022 Q1 | 17.53 Billion JPY | 4.26% |
| 2022 FY | 18.23 Billion JPY | 8.43% |
| 2022 Q4 | 18.23 Billion JPY | 1.04% |
| 2022 Q3 | 18.05 Billion JPY | 3.83% |
| 2022 Q2 | 17.38 Billion JPY | -0.86% |
| 2021 FY | 16.82 Billion JPY | 6.78% |
| 2021 Q1 | 15.9 Billion JPY | 0.98% |
| 2021 Q2 | 16.23 Billion JPY | 2.08% |
| 2021 Q3 | 16.51 Billion JPY | 1.69% |
| 2021 Q4 | 16.82 Billion JPY | 1.87% |
| 2020 Q2 | 12.87 Billion JPY | 3.38% |
| 2020 Q3 | 14.56 Billion JPY | 13.14% |
| 2020 Q4 | 15.75 Billion JPY | 8.17% |
| 2020 Q1 | 12.45 Billion JPY | 2.63% |
| 2020 FY | 15.75 Billion JPY | 29.85% |
| 2019 Q3 | 11.46 Billion JPY | 11.04% |
| 2019 FY | 12.13 Billion JPY | 20.59% |
| 2019 Q4 | 12.13 Billion JPY | 5.8% |
| 2019 Q1 | 10.98 Billion JPY | 9.21% |
| 2019 Q2 | 10.32 Billion JPY | -6.0% |
| 2018 FY | 10.05 Billion JPY | 8.06% |
| 2018 Q3 | 9.96 Billion JPY | 5.6% |
| 2018 Q2 | 9.43 Billion JPY | -3.17% |
| 2018 Q1 | 9.74 Billion JPY | 4.66% |
| 2018 Q4 | 10.05 Billion JPY | 0.98% |
| 2017 Q2 | 9.2 Billion JPY | -5.77% |
| 2017 FY | 9.3 Billion JPY | 9.6% |
| 2017 Q4 | 9.3 Billion JPY | -5.61% |
| 2017 Q3 | 9.86 Billion JPY | 7.15% |
| 2017 Q1 | 9.76 Billion JPY | 15.0% |
| 2016 Q4 | 8.49 Billion JPY | -8.79% |
| 2016 FY | 8.49 Billion JPY | 21.61% |
| 2016 Q1 | 7.86 Billion JPY | 12.58% |
| 2016 Q3 | 9.31 Billion JPY | 11.78% |
| 2016 Q2 | 8.32 Billion JPY | 5.94% |
| 2015 Q4 | 6.98 Billion JPY | -5.13% |
| 2015 Q3 | 7.36 Billion JPY | 10.88% |
| 2015 Q2 | 6.63 Billion JPY | 3.02% |
| 2015 FY | 6.98 Billion JPY | 30.49% |
| 2015 Q1 | 6.44 Billion JPY | 20.41% |
| 2014 Q1 | 5.37 Billion JPY | 21.07% |
| 2014 Q3 | 5.66 Billion JPY | 10.9% |
| 2014 Q4 | 5.35 Billion JPY | -5.53% |
| 2014 FY | 5.35 Billion JPY | 20.64% |
| 2014 Q2 | 5.1 Billion JPY | -4.89% |
| 2013 Q1 | 5.26 Billion JPY | 31.04% |
| 2013 Q3 | 5.54 Billion JPY | 11.42% |
| 2013 Q4 | 4.43 Billion JPY | -20.05% |
| 2013 FY | 4.43 Billion JPY | 10.42% |
| 2013 Q2 | 4.98 Billion JPY | -5.42% |
| 2012 Q1 | 3.97 Billion JPY | 16.37% |
| 2012 FY | 4.01 Billion JPY | 17.53% |
| 2012 Q3 | 4.69 Billion JPY | 26.52% |
| 2012 Q2 | 3.71 Billion JPY | -6.72% |
| 2012 Q4 | 4.01 Billion JPY | -14.42% |
| 2011 Q1 | 4.13 Billion JPY | 18.61% |
| 2011 Q2 | 3.53 Billion JPY | -14.49% |
| 2011 FY | 3.41 Billion JPY | -1.92% |
| 2011 Q3 | 4.12 Billion JPY | 16.63% |
| 2011 Q4 | 3.41 Billion JPY | -17.1% |
| 2010 Q2 | 3.39 Billion JPY | -1.13% |
| 2010 Q4 | 3.48 Billion JPY | -6.86% |
| 2010 Q3 | 3.74 Billion JPY | 10.38% |
| 2010 FY | 3.48 Billion JPY | 19.79% |
| 2010 Q1 | 3.42 Billion JPY | 0.0% |
| 2009 FY | 2.9 Billion JPY | -6.09% |
| 2008 FY | 3.09 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -211.002% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 98.273% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 81.89% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 67.82% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -941.358% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 46.588% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | -21.687% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 88.039% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -555.887% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 1.351% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 31.006% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -47.092% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -94.833% |
| Tsumura & Co. | 117.61 Billion JPY | 82.239% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 20.558% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -94.47% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 79.332% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | -7.842% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | -44.171% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 60.931% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -970.184% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -8903.146% |
| MedRx Co., Ltd | 10 Million JPY | -208800.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -1208.399% |
| Solasia Pharma K.K. | 122 Million JPY | -17022.951% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -328721.029% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | -2.392% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 79.11% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -45268.661% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 76.067% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -821.784% |